Radionuclide therapy with samarium oxabifore (<sup>153</sup>Sm) in patients with prostate cancer and bone metastases
Objective: To study the clinical capacities of the radiopharmaceutical samarium oxabifore (153Sm) in palliative therapy in prostate cancer patients with bone metastases and pain syndrome.Subjects and methods: 53 patients with prostate cancer and multiple bone metastases and pain syndrome in whom 153...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2020-02-01
|
| Series: | Onkourologiâ |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1088 |